Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Ademetionine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDR known ✓ | P35968 | 1/20 | 0.98 |
| ▸ | CARM1 | Q86X55 | 5/20 | 0.98 |
| ▸ | PCMT1 | P22061 | 3/20 | 0.98 |
| ▸ | PRMT5 | O14744 | 3/20 | 0.98 |
| ▸ | PRMT1 | Q99873 | 3/20 | 0.98 |
| ▸ | NSD3 | Q9BZ95 | 2/20 | 0.98 |
| ▸ | PRMT3 | O60678 | 2/20 | 0.98 |
| ▸ | PNMT | P11086 | 2/20 | 0.98 |
| ▸ | PRMT6 | Q96LA8 | 2/20 | 0.98 |
| ▸ | WDR77 | Q9BQA1 | 2/20 | 0.98 |
| ▸ | PRMT7 | Q9NVM4 | 2/20 | 0.98 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.98 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.98 |
| ▸ | AMD1 | P17707 | 5/20 | 0.85 |
| ▸ | NNMT | P40261 | 3/20 | 0.61 |
| ▸ | DOT1L | Q8TEK3 | 4/20 | 0.60 |
| ▸ | EHMT2 | Q96KQ7 | 4/20 | 0.60 |
| ▸ | NSD2 | O96028 | 3/20 | 0.60 |
| ▸ | SETD7 | Q8WTS6 | 3/20 | 0.60 |
| ▸ | TRDMT1 | O14717 | 2/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ademetionine SCHEMBL25176 | 0.99 | CARM1 (1.00) | CARM1PCMT1PRMT5PRMT1NSD3 | |
| Ademetionine SCHEMBL1300198 | 0.99 | CARM1 (1.00) | CARM1PCMT1PRMT5PRMT1NSD3 | |
| Ademetionine SCHEMBL1300205 | 0.99 | CARM1 (1.00) | CARM1PCMT1PRMT5PRMT1NSD3 | |
| Ademetionine SCHEMBL29355793 | 0.99 | CARM1 (1.00) | CARM1PCMT1PRMT5PRMT1NSD3 | |
| Ademetionine SCHEMBL1980696 | 0.98 | CARM1 (0.98) | CARM1PCMT1PRMT5PRMT1NSD3 | |
| Ademetionine SCHEMBL3208346 | 0.94 | CARM1 (0.89) | CARM1PCMT1PRMT5PRMT1NSD3 | |
| Ademetionine SCHEMBL29421543 | 0.93 | CARM1 (0.89) | CARM1PCMT1PRMT5PRMT1NSD3 | |
| Ademetionine SCHEMBL29986218 | 0.93 | CARM1 (0.98) | CARM1PCMT1PRMT5PRMT1NSD3 | |
| Ademetionine SCHEMBL5465751 | 0.93 | CARM1 (0.88) | CARM1PCMT1PRMT5PRMT1NSD3 | |
| Ademetionine SCHEMBL7192080 | 0.92 | CARM1 (0.93) | CARM1PCMT1PRMT5PRMT1NSD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240218351-A1 | SINGLE STRANDED RNA PURIFICATION METHODS | NOVO NORDISK A/S (DK) | 2024-07-04 | — | — | US | disclosed |
| CN-117730149-A | Single-stranded RNA purification method | 2赛文缇生物公司 | 2024-03-19 | — | — | CN | disclosed |
| US-20140227318-A1 | SLEEP QUALITY IMPROVING AGENT | LION CORPORATION (JP) | 2014-08-14 | — | — | US | disclosed |
| EP-2764869-A1 | AGENT FOR IMPROVING QUALITY OF SLEEP | Lion Corporation (JP) | 2014-08-13 | — | — | EP | disclosed |
| CN-103841985-A | Agent for improving quality of sleep | LION CORP | 2014-06-04 | — | — | CN | disclosed |
| WO-2008107711-A1 | PARTIALLY-METHYLATED BREAK LIGHT ASSAY FOR DNA METHYLTRANSFERASE ACTIVITY | UNIVERSITY OF SOUTHAMPTON (GB) | 2008-09-12 | — | — | WO | disclosed |
| US-6635615-B1 | Stable salts of S-adenosyl-l-methionine | HEBERT SAM-E LLC | 2003-10-21 | — | — | US | disclosed |